HCV POL

Therapy Area

Treatment of hepatitis C virus infection.

In phase

Preclinical development stage in collaboration with Tibotec, Johnson & Johnson.

Competitive Edge

Potent HCV polymerase inhibitors has been identified.

Project Data

Candidate Drug (CD) was selected in December 2008.


Last Modified: 12/05/2009